Stoke Therapeutics STOK
NASDAQ STOK
$26.87 -0.84 (-3.03%)
As of: Nov 10, 2026 · 1:53 PM EST

Stoke Therapeutics (STOK) Net Long-Term Debt Issued (Repaid) (2019 - 2020)

Updated

Stoke Therapeutics' Net Long-Term Debt Issued (Repaid) was -$1,000 in Q1 2020, compared with -$1,000 a year earlier.

Analysis

Stoke Therapeutics (STOK) Net Long-Term Debt Issued (Repaid) (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Stoke Therapeutics 1.90 Bn 658.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -1,000.00
Mar 31, 2019 -1,000.00
API Access

Stoke Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=STOK&period=max&api_key=YOUR_API_KEY